The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Marketwire

Theratechnologies Obtains US Patent for Improving Cognitive Function with Tesamorelin in Patients Suffering from MCI

Thursday, July 11, 2013

Theratechnologies Obtains US Patent for Improving Cognitive Function with Tesamorelin in Patients Suffering from MCI

07:30 EDT Thursday, July 11, 2013

MONTREAL, CANADA--(Marketwired - July 11, 2013) - Theratechnologies Inc. (TSX:TH) today announced that the US Patent and Trademark Office (USPTO) has issued Patent No. 8,481,489 entitled "GH Secretagogues and Uses Thereof" covering a method of improving cognitive function in a subject suffering from mild cognitive impairment (MCI) through the administration of tesamorelin. The patent will expire in 2024.

"We are glad the USPTO delivered this patent as it enlarges the protection of tesamorelin for use in a potential therapeutic area" stated Luc Tanguay, President and Chief Executive Officer of Theratechnologies.

About Theratechnologies

Theratechnologies (TSX:TH) is a biopharmaceutical company that specializes in innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on the SEC's website at www.sec.gov.

FOR FURTHER INFORMATION PLEASE CONTACT:

Contact Information:
Denis Boucher
NATIONAL Public Relations
514-843-2393

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections